These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30441448)

  • 1. A Deep Deterministic Policy Gradient Approach to Medication Dosing and Surveillance in the ICU.
    Lin R; Stanley MD; Ghassemi MM; Nemati S
    Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():4927-4931. PubMed ID: 30441448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal medication dosing from suboptimal clinical examples: a deep reinforcement learning approach.
    Nemati S; Ghassemi MM; Clifford GD
    Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():2978-2981. PubMed ID: 28268938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse reinforcement learning for intelligent mechanical ventilation and sedative dosing in intensive care units.
    Yu C; Liu J; Zhao H
    BMC Med Inform Decis Mak; 2019 Apr; 19(Suppl 2):57. PubMed ID: 30961594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dosing strategy model of deep deterministic policy gradient algorithm for sepsis patients.
    Lin T; Zhang X; Gong J; Tan R; Li W; Wang L; Pan Y; Xu X; Gao J
    BMC Med Inform Decis Mak; 2023 May; 23(1):81. PubMed ID: 37143048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-Specific Sedation Management via Deep Reinforcement Learning.
    Eghbali N; Alhanai T; Ghassemi MM
    Front Digit Health; 2021; 3():608893. PubMed ID: 34713090
    [No Abstract]   [Full Text] [Related]  

  • 6. An evaluation of empiric vs. nomogram-based dosing of heparin in an intensive care unit.
    Brown G; Dodek P
    Crit Care Med; 1997 Sep; 25(9):1534-8. PubMed ID: 9295828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward Optimal Heparin Dosing by Comparing Multiple Machine Learning Methods: Retrospective Study.
    Su L; Liu C; Li D; He J; Zheng F; Jiang H; Wang H; Gong M; Hong N; Zhu W; Long Y
    JMIR Med Inform; 2020 Jun; 8(6):e17648. PubMed ID: 32568089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-induced thrombocytopenia in intensive care patients.
    Selleng K; Warkentin TE; Greinacher A
    Crit Care Med; 2007 Apr; 35(4):1165-76. PubMed ID: 17334253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Argatroban dosage requirements and outcomes in intensive care versus non-intensive care patients.
    Smythe MA; Koerber JM; Forsyth LL; Priziola JL; Balasubramaniam M; Mattson JC
    Pharmacotherapy; 2009 Sep; 29(9):1073-81. PubMed ID: 19698012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep Reinforcement Learning for Optimal Critical Care Pain Management with Morphine using Dueling Double-Deep Q Networks.
    Lopez-Martinez D; Eschenfeldt P; Ostvar S; Ingram M; Hur C; Picard R
    Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():3960-3963. PubMed ID: 31946739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reinforcement Learning for Clinical Decision Support in Critical Care: Comprehensive Review.
    Liu S; See KC; Ngiam KY; Celi LA; Sun X; Feng M
    J Med Internet Res; 2020 Jul; 22(7):e18477. PubMed ID: 32706670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transatlantic transferability of a new reinforcement learning model for optimizing haemodynamic treatment for critically ill patients with sepsis.
    Roggeveen L; El Hassouni A; Ahrendt J; Guo T; Fleuren L; Thoral P; Girbes AR; Hoogendoorn M; Elbers PW
    Artif Intell Med; 2021 Feb; 112():102003. PubMed ID: 33581824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guideline-informed reinforcement learning for mechanical ventilation in critical care.
    den Hengst F; Otten M; Elbers P; van Harmelen F; François-Lavet V; Hoogendoorn M
    Artif Intell Med; 2024 Jan; 147():102742. PubMed ID: 38184349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial.
    Fowler RA; Mittmann N; Geerts WH; Heels-Ansdell D; Gould MK; Guyatt G; Krahn M; Finfer S; Pinto R; Chan B; Ormanidhi O; Arabi Y; Qushmaq I; Rocha MG; Dodek P; McIntyre L; Hall R; Ferguson ND; Mehta S; Marshall JC; Doig CJ; Muscedere J; Jacka MJ; Klinger JR; Vlahakis N; Orford N; Seppelt I; Skrobik YK; Sud S; Cade JF; Cooper J; Cook D; ;
    Trials; 2014 Dec; 15():502. PubMed ID: 25528663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal replacement therapy for acute renal failure (VERROU-REA study): study protocol for a randomized controlled trial.
    Bruyère R; Soudry-Faure A; Capellier G; Binquet C; Nadji A; Torner S; Blasco G; Yannaraki M; Barbar SD; Quenot JP
    Trials; 2014 Nov; 15():449. PubMed ID: 25409678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.
    Hull RD; Pineo GF; Stein P
    Int Angiol; 1998 Dec; 17(4):213-24. PubMed ID: 10204652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, multicenter trial of weight-adjusted intravenous heparin dose titration and point-of-care coagulation monitoring in hospitalized patients with active thromboembolic disease. Antithrombotic Therapy Consortium Investigators.
    Becker RC; Ball SP; Eisenberg P; Borzak S; Held AC; Spencer F; Voyce SJ; Jesse R; Hendel R; Ma Y; Hurley T; Hebert J
    Am Heart J; 1999 Jan; 137(1):59-71. PubMed ID: 9878937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The accuracy of a point of care measurement of activated partial thromboplastin time in intensive care patients.
    Karigowda L; Deshpande K; Jones S; Miller J
    Pathology; 2019 Oct; 51(6):628-633. PubMed ID: 31445807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of different anticoagulants in test tubes for analysis of blood lactate concentrations: Part 2. Implications for the proper handling of blood specimens obtained from critically ill patients.
    Wiese J; Didwania A; Kerzner R; Chernow B
    Crit Care Med; 1997 Nov; 25(11):1847-50. PubMed ID: 9366768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration.
    Reeves JH; Cumming AR; Gallagher L; O'Brien JL; Santamaria JD
    Crit Care Med; 1999 Oct; 27(10):2224-8. PubMed ID: 10548211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.